ALEX GUZMAN GARCIA: Open Payments
NPI 1558635045 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 37 payments from 15 companies in 2025. Trend: 2023 $674 · 2024 $586 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $204 |
| Abbott Laboratories | 4 | $106 |
| Novo Nordisk Inc | 5 | $99 |
| Exact Sciences Corporation | 5 | $85 |
| Lilly USA, LLC | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $28 |
Products named: BREZTRI, FREESTYLE LIBRE 3, AIRSUPRA, Ozempic, Cologuard Collection Kit, MOUNJARO, JARDIANCE, Kerendia.
Industry payments across AZ — which companies pay providers there.
